The HelioLiver test helps you learn about your risk for liver cancer and be proactive about your care. HelioLiver is now available for clinical use as a laboratory-developed test (LDT).
The current testing methods can’t always detect liver cancer in the earliest stages. Once you’ve been diagnosed as at-risk for liver cancer, you know it’s important to keep up with routine liver cancer testing.
The HelioLiver laboratory-developed test is a testing method that has been shown in clinical trials to detect liver in early stages. With a simple blood draw, this test provides early detection insights that help you be proactive about your health.
Just get one blood draw during your routine doctor’s visit that takes no more than 5 minutes
Our test is more sensitive than other currently available surveillance methods with simple, easy-to-understand results
We can bill most insurances, and accept all commercial and federal plans.
Fill out this short form and someone from the HelioLiver LDT team will be in touch!